source
- Mid-size biotech firms urge White House to scrap CMS GLOBE and GUARD pricing proposalsA group of midsized biotechnology companies met with officials from the White House and the Department of Health and Human Services this week. The companies presented a coordinated case to senior p…
- Celcuity's Revtorpyk receives FDA approval, but launch delay pushes stock lowerThe FDA announced approval of Celcuity’s oncology candidate Revtorpyk on Tuesday, marking the company’s first cancer drug clearance. Analysts had broadly expected the approval and had priced the s…